Category: New products
-
Blood Test as Good as Biopsy to Detect Cancer Targets
Results of a clinical trial show a commercial blood test works at least as well as tissue biopsies for determining precise genetic mutations causing most lung cancers.
-
Anti-Inflammatory Human Protein Produced in Plants
Researchers in Canada genetically engineered tobacco plants to economically produce large quantities of a human protein with anti-inflammatory properties.
-
Trials Underway Testing Crispr for Blood Disorders
Clinical trials testing the genome editing technique Crispr for sickle cell disease and beta thalassemia, two inherited blood disorders, enrolled and infused their first patients.
-
Gene Editing Deactivates Cause of T-Cell Side Effects
A biotechnology company developing engineered T-cells as treatments for cancer, used gene editing to deactivate a likely cause of serious adverse effects from its therapies.
-
Organoids Designed for Faster Cancer Diagnostics
A new process grows small samples of tumor tissue in the lab to enable high-speed diagnostics for personalized cancer treatments and drug testing.
-
Blockchain Prototype Designed for Clinical Trial Data
A bioinformatics lab developed a prototype system for securely transmitting and storing clinical trial data with blockchain that protects against corrupting trial records.
-
Prosthetic Hand Gives Better Sense of Position, Movement
22 Feb. 2019. An advance in prosthetics and robotics enables artificial hands to provide a more natural sense of position and reach in the dark or without looking at objects. Researchers from institutions in Switzerland and Italy describe this development in the 20 February issue of the journal Science Robotics. A team from École Polytechnique…
-
Targeted Chemo Seen Benefiting Breast Cancer Patients
A clinical trial shows a treatment combining an antibody and chemotherapy drug invokes a response and longer survival time in many patients with metastatic triple-negative breast cancer.
-
Trial Shows RNA Therapy Safe for Diabetes
Results from a clinical trial show a new drug with synthetic messenger RNA is safe for people with diabetes, and has the potential to promote new blood vessel growth.
-
High-Speed Screens, A.I., Boost Nanoscale Medicines
Biomedical engineers are using high-throughput screening techniques and machine learning to speed and improve the design of new drugs based on nanoscale particles.